16-89771757-T-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM1BP4_StrongBP6
The NM_000135.4(FANCA):c.2072A>G(p.Asn691Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000576 in 1,613,998 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N691D) has been classified as Uncertain significance.
Frequency
Consequence
NM_000135.4 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCA | ENST00000389301.8 | c.2072A>G | p.Asn691Ser | missense_variant | Exon 23 of 43 | 1 | NM_000135.4 | ENSP00000373952.3 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152164Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000835 AC: 21AN: 251486 AF XY: 0.0000809 show subpopulations
GnomAD4 exome AF: 0.0000568 AC: 83AN: 1461834Hom.: 0 Cov.: 34 AF XY: 0.0000454 AC XY: 33AN XY: 727202 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152164Hom.: 1 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Fanconi anemia complementation group A Uncertain:2Benign:1
The FANCA c.2072A>G (p.Asn691Ser) missense change has a maximum subpopulation frequency of 0.043% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a benign effect of this variant on protein function (BP4), but to our knowledge these predictions have not been confirmed by functional assays. To our knowledge, this variant has not been reported in individuals with Fanconi anemia. In summary, this variant meets criteria to be classified as of uncertain significance based on the ACMG/AMP criteria: BP4. -
- -
- -
not specified Uncertain:1Other:1
- -
- -
not provided Uncertain:1
The FANCA c.2072A>G (p.Asn691Ser) variant has been detected in the published literature in an individual with myeloid malignancy (PMID: 31911633 (2020)) and in reportedly healthy individuals (PMIDs: 24728327 (2014) and 32546565 (2021)).The frequency of this variant in the general population, 0.00043 (15/34588 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is benign. Based on the available information, we are unable to determine the clinical significance of this variant. -
Fanconi anemia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at